Author name: John LaRosa

April 6, 2015 — The company announced a massive board overhaul. CEO Michael MacDonald acknowledged that activists did play a part in shaping the changes at Medifast. Eight people will leave the company’s board as the body shrinks from 12 people to nine. Activists, including Glenn W. Welling of California-based Engaged Capital LLC, sped the […]

March 12, 2015 — According to a press release…For the 4th quarter 2014, Medifast net revenue fell 11% to $62.3 million from net revenue of $70.3 million in Q4 2013. As a result of the closure and sale of the Medifast Corporate Weight Control Centers, the Company re-evaluated its segment reporting and will no longer

March 3, 2015 – According to Dawn Zier, President and CEO: “I am pleased we have delivered six consecutive quarters of year-over-year revenue growth. Our strong results for fiscal 2014 demonstrate the successful execution of our turnaround plan as well as our ability to be nimble and proactively address evolving customer needs. We’re attracting new

Feb. 26, 2015 – The news was not good, again. Total year 2014 sales of $1.479 billion.  Fiscal 2014 revenues decreased 14.2% versus the prior year. This decrease was primarily driven by lower revenues in North America. Online revenues (WW.com subscribers) of $437 mill. (-16.7%) Planned $100 million cost reductions (staff layoffs). Expected 2015 revenues

Feb. 24, 2015 — According to a news release, all Humana members in qualified employer-sponsored health plans now have free and discounted access to Weight Watchers through an integrated wellness program built into their health plan, giving Humana members a proven  approach to change their lifestyle and improve their health. This new program integrates Weight

“The U.S. Weight Loss Market: 2015 Status Report & Forecast” — January 2015, 64 pp.  Price: $595 —    This new report presents a wrap-up of 2014 performance for the U.S. weight loss market and an outlook for the 2015 “diet season”. The value of the market actually declined by 1.1% to $59.8 billion, largely as

We are sorry to inform readers that we have had to postpone the weight loss conference that was scheduled for March 13-14 in Orlando, due to insufficient registrations. We may try again later this year or next.

Dr. Phil McGraw’s new book, The 20/20 Diet, is on the top of the bestseller list as of the first week of Feb. 2015. Dr. Phil’s no nonsense style addresses various weight loss roadblocks by applying the latest research and theories that have emerged since his last bestseller on the same topic, The Ultimate Weight

Contrave, a diet drug by Orexigen, has received a recommendation for European approval. Orexigen will change the brand name of Contrave to Mysimba for marketing in Europe, once final approval is granted early next year. The other new diet drugs, Belviq and Qsymia, have not been big sellers – considering that more than a third of

“Launching A Successful Medical Weight Loss Program” will be a unique 2-day conference held in Orlando, march 13-14, 2015. See the video to the left on this home page and the website DietShow2015.com, to register, for speakers and the agenda. Sponsors and exhibitors welcome. Contact Marketdata for details or questions. The momentum today is with